• Pulmonary Disease

    Mona Bafadhel is Associate Professor in the Nuffield Department of Medicine, University of Oxford, and an Honorary Consultant at Oxford University Hospitals Trust. Associate Professor Bafadhel graduated from the University of Birmingham, UK, undertaking her junior medical training in Birmingham and then at the Royal Brompton Hospital, London. Associate Professor Bafadhel completed her specialist training in respiratory medicine at Oxford, and completed a PhD on identification of subgroups of patients with COPD and their varied responses to treatment at the University of Leicester, UK. Associate Professor Bafadhel’s research and clinical interests are in the field of airways disease, particularly COPD, investigating the mechanisms and therapeutic strategies aligned to using phenotypes. Her ongoing research focus is to develop a further understanding of the pathophysiology of COPD and deliver therapeutic strategies to patients across the spectrum. Associate Professor Bafadhel has published over 30 peer-reviewed articles in her field.

    • Pulmonary Disease
    • National Institute for Health Research Senior Investigator, Director of the Leicester NIHR Biomedical Research Unit, and Honorary Consultant Respiratory Physician at Institute for Lung Health
    Christopher Brightling is a National Institute for Health Research Senior Investigator, Director of the Leicester NIHR Biomedical Research Unit and Honorary Consultant Respiratory Physician at the Institute for Lung Health, Leicester, UK. He is Coordinator for the European Union Consortium AirPROM, MRC/ABPI COPD (COPDMAP) Consortium and the MRC Molecular Pathology Node EMBER. He is founding Director of the ERS Clinical Research Collaborations. As a well-respected expert in the immunopathogenesis of airway diseases, particularly asthma, chronic cough and COPD, his current projects include understanding the interactions between mast cells and airway smooth muscle cells in the development of the asthmatic phenotype, and migration and remodeling of airway smooth muscle in asthma and COPD. Professor Brightling has published over 300 peer-reviewed articles and has an h-index of 76 (google scholar). He has been an invited speaker at over 20 international meetings within the last 5 years. Professor Brightling is Associate Editor of the prestigious CHEST and Clinical Science journals and has contributed to updates for the American College of Chest Physicians’ Cough Guidelines, the British Thoracic Society Difficult Asthma Guidelines and the American Thoracic Society/European Respiratory Society Severe Asthma Task Force.
    • Pulmonary Disease
    • Head of Respiratory Clinical Research and Development at GlaxoSmithKline plc

    Dr. Pascoe is the Head of Respiratory Clinical Research and Development at GSK.

    • Pulmonary Disease
    • Head of the Respiratory Clinical Science Division & Professor of Respiratory Medicine at the National Heart and Lung Institute at Imperial College

    Wisia Wedzicha is Professor of Respiratory Medicine at the National Heart and Lung Institute, Imperial College, UK and Head of the Respiratory Clinical Science Division. She qualified from Somerville College, Oxford University and St Bartholomew’s Hospital Medical College, University of London. She was elected as Fellow of the Academy of Medical Sciences (FMedSci) in 2013 and is an National Institute of Health Research (NIHR) Senior Investigator. She received the Helmholtz International Fellow Award in 2014. Professor Wedzicha has a major interest in the causes, mechanisms, impact and prevention of chronic obstructive pulmonary disease (COPD) exacerbations, and in the role of bacterial and viral infection in COPD exacerbations. She directs an active research group specialising in COPD exacerbations, and has published extensively on this topic. Professor Wedzicha chaired the English Department of the Health Home Oxygen Clinical User Group, and was a member of the Guideline Development Group for the revision of the National Institute for Healthcare and Clinical Excellence COPD Guidelines. In 2016, she has been appointed as an Expert Adviser to the NICE Centre for Clinical Practice. Professor Wedzicha was Editor-in- Chief of Thorax from 2002 to 2010, and is a member of the BioMed Central advisory board. She is currently Editor in Chief for the American Journal of Respiratory and Critical Care Medicine. In addition, she is on the editorial boards of a number of international journals. She was the Lancet Ombudsman till 2014, Publications Director for the European Respiratory Society (ERS) and has also previously been ERS Guidelines Director.

    • Pulmonary Disease
    • Professor of Clinical Pharmacology & Respiratory Medicine at University of Manchester

    Dave Singh is Professor of clinical pharmacology & respiratory medicine at the University of Manchester. He graduated from Cambridge University and trained in clinical pharmacology and respiratory medicine in Manchester, including postgraduate research. His research interest is the development of new drugs for asthma and COPD, involving clinical trials, biomarker studies and basic mechanisms. He has over 200 publications in peer reviewed journals. He is a member of the GOLD Science Committee.

    • Pulmonary Disease
    • Professor of Pulmonary Medicine & Honorary Consultant Physician at University Hospital Aintree

    Professor Calverley is a Professor of Pulmonary Medicine at the University of Liverpool, UK and

    Honorary Consultant Physician at the University Hospital Aintree, Liverpool. He has a long-standing

    interest in COPD and has published a number of large clinical studies on this topic.


    Currently Professor Calverley is an Associate Editor of the American Journal of Respiratory and

    Critical Care Medicine, having previously served in this role with Thorax and the European

    Respiratory Journal. He was Chairman of the Clinical Physiology Assembly of the European

    Respiratory Society and served on its Executive. Now he is the COPD advocate for the ERS. He has

    served on many groups developing COPD Guidelines including GOLD and NICE as well as the joint

    ATS/ERS guidelines group. He chaired the UK Department of Health Working Group which developed

    a UK strategy for COPD Care.

    • Pulmonary Disease

    I am a Pulmonary and Critical Care physician with expertise in airway diseases including asthma and COPD. I oversee the Airways Clinical Research Center at Baylor which includes a large research team of co-investigators and coordinators. Our team is involved in single-center and multi-center collaborative clinical trials. Our funding includes the American Lung Association, the NIH as well as industry. My research is primarily focused on airway pharmacology and is based on translating findings from lab to the clinic with the hope to develop new treatments. In addition to my research activities, I am the Director of the Asthma and COPD Clinic at the Smith Clinic/ Ben Taub Hospital. My ultimate goal is to improve the outcome of patients with asthma and COPD not only by providing state of the art evidence-based care, but by developing and testing new interventions to eliminate burden of these diseases.

Powered by Medstro